Intervention

Isosorbide Dinitrate

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting2

Common conditions9

Lead sponsors shown7

Clinical trials

7 shown

DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart FailureNCT05276219 · 2023-09-14

Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsNCT06218199 · 2021-07-08

Hypertensive Heart Failure Treatment in SSANCT06400784 · 2022-03-25

Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHFNCT02649998 · 2017-01-01

Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) StudyNCT02343393 · 2015-01-01

Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart FailureNCT01822808 · 2013-01-01

Vasodilator Therapy for Heart Failure and Preserved Ejection FractionNCT01516346 · 2012-01-01

Common conditions

Acute Heart Failure2 Congestive Heart Failure2 A Feasibility Study on Hypertensive Heart Failure Treatment1 Cardio-Renal Syndrome1 Heart Decompensation1 Heart Failure1 Heart Failure, Congestive1 Left Ventricular Dysfunction1 Pulmonary Edema1

Leading sponsors

Chinese University of Hong Kong1 Copenhagen University Hospital, Rigshospitalet1 Corporal Michael J. Crescenz VA Medical Center1 Heart Center Research, LLC1 National University Hospital, Singapore1 University of Abuja1 University of Cape Town1

Trial status mix

COMPLETED2

RECRUITING2

UNKNOWN2

WITHDRAWN1

Phase mix

PHASE43

PHASE32

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.